3570. Adulteration  and  misbranding  of Hemoplex and  Livofer-B.   U.  S. v.
Bellevue Laboratories, Inc., and Chaim Dick. Pleas of guilty. Fine of
$250 against corporation. Imposition of sentence against individual
suspended and individual placed on probation for 1 year.    (F. D. C. No.
No. 29457.   Sample Nos. 73652-K, 73666-K.)
INFORMATION FILED : September 24,1951, Southern District of New York, against
Bellevue Laboratories
 Inc., New York, N. Y., and Chaim Dick, president-
treasurer of the corporation.
ALLEGED SHIPMENT : On or about January 19, 1950, from the State of New York
into the State of New Jersey.
NATURE OF CHARGE : Adulteration^ Section 501 (c), the purity of the articles fell
below that which they purported and were represented to possess, in that the
articles were not sterile and were not suitable for intramuscular injection since
they were contaminated with viable sporef orming bacteria.
Misbranding, Section 502 (a), the statement "Sterile * * * For Intra-
muscular Use" displayed upon the label of the Hemoplex and the statement
"Sterile * * * Intramuscular" displayed upon the label of the Livofer-B
were false and misleading. Such statements represented and suggested that
the articles were sterile and suitable for intramuscular injection, whereas the
articles were not sterile and suitable for intramuscular injection since they
were contaminated with viable sporef orming bacteria.
DISPOSITION : November 13,1951. Pleas of guilty having been entered, the court
imposed a fine of $250 against the corporation and suspended the imposition
of sentence against the individual defendant and placed him on probation
for 1 year.